Muscle relaxants and psilocybin.
6 records in this group. None has published human data with psilocybin or another classic psychedelic; the rest draw on each medication's own pharmacology and label. State rules are summarized for Colorado, Oregon and New Mexico.
Also searched as muscle relaxant
01 What the evidence covers
Best evidence available per medication| 6 | No psilocybin data No psilocybin data: no human data with psilocybin or another classic psychedelic; the text draws on the medication's own pharmacology and its label or reference facts |
02 Each medication
A to ZMuscle spasticity from multiple sclerosis; Spasticity from spinal cord injury or disease
Its sleepiness may add to psilocybin's effects. Stopping it suddenly after regular use can cause seizures.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Short-term relief of acute, painful musculoskeletal conditions
Not studied with psilocybin; this sedating muscle relaxant adds to alcohol, benzodiazepines and opioids. Stopping it suddenly after regular use can cause withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Muscle spasm from acute, painful musculoskeletal conditions (with rest and physical therapy); Fibromyalgia in adults (sublingual Tonmya only)
It is described as blocking the receptor family psilocybin works through, so it may weaken psilocybin; the net effect is untested.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
- MetaxaloneEvidence: No psilocybin data
Acute, painful musculoskeletal conditions (with rest and physical therapy)
Not studied with psilocybin. It is sedating, and its label reports serotonin syndrome with serotonin-boosting drugs, so added effects are possible.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Acute painful musculoskeletal conditions (with rest and physical therapy)
Its sleepiness and dizziness may add to psilocybin's effects; it does not act on serotonin.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Spasticity (muscle stiffness)
Its sedation and possible hallucinations may add to psilocybin's effects. Stopping it suddenly after regular use can cause rebound high blood pressure.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
03 Properties the records flag
Records with each flag| 6 | Sedating or CNS depressant |
| 4 | Withdrawal or rebound if stopped abruptly |
| 3 | Lowers seizure threshold or carries seizure risk |
| 2 | Psychiatric reactions |
| 2 | Serotonergic |
| 1 | Anticholinergic |
| 1 | Blocks 5-HT2A (may blunt effects) |
| 1 | Liver injury |
| 1 | Lowers blood pressure or causes orthostasis |
Flags describe a medication's own properties, each cited in its record. A flag is not a finding about any combination. Definitions are on the Method page.
04 State rules
Official text governsNo provision names these medications or this group.
No provision names these medications or this group.
Rules not final; the proposed rules reviewed name no medication in this group.
05 Studies cited in this group
Records citing eachRecords reviewed 2026-10-03 to 2026-10-04. Each row summarizes one record; the full record, with every source, opens in the browser and is not sent to the server. All classes · Browse A–Z